ABclonal Biotechnology Acquires Yurogen Biosystems to Better Serve Diagnostic and Pharmaceutical Researchers Worldwide News provided by Share this article Share this article BOSTON, March 5, 2021 /PRNewswire/ -- ABclonal Biotechnology Co., Ltd., a global life science tools and services provider, acquires Yurogen Biosystems LLC, a contract research organization dedicated to monoclonal antibody discovery using single-B-cell-based SMab TM platform, to better serve researchers in in vitro diagnostic, and antibody drug and therapeutic discovery markets worldwide. The acquisition comes after the c...